A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2010-08-25
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01188031
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2010-08-25
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01188057
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis
- Conditions
- Actinic Keratoses
- Interventions
- First Posted Date
- 2009-07-29
- Last Posted Date
- 2020-09-04
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 462
- Registration Number
- NCT00948428
- Locations
- 🇺🇸
Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
🇺🇸Associates in Research, Inc., Fresno, California, United States
🇺🇸Skin Surgery Medical Group, Inc., San Diego, California, United States
A Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-30
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00871364
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Montreal, Quebec, Canada
A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fed Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-30
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00871247
- Locations
- 🇨🇦
SFBC Anapharm, Sainte-Foy, Quebec, Canada
A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00870142
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Montreal, Quebec, Canada
A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00870480
- Locations
- 🇨🇦
SFBC Anapharm, Sainte-Foy, Quebec, Canada
A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-27
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00870571
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent, Montreal, Quebec, Canada
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Non-fasting Conditions
- Conditions
- Healthy
- Interventions
- Drug: CLUCOPHAGE® XR 500 mg tablets, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00864669
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions
- Conditions
- Healthy
- Interventions
- Drug: CLUCOVANCE® 5 mg/500 mg Tablets, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00864734
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States